Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium

10.1097/00004397-200201000-00003

10.1097/00004397-199603610-00019

10.1136/bjo.80.5.480

10.1096/fj.03-0645rev

10.2165/00002018-200225090-00003

Fry SW, 1995, Gastroenterol Clin North Am, 24, 875, 10.1016/S0889-8553(21)00232-6

10.1517/14740338.1.2.181

Fraunfelder FT, 1993, Blood dyscrasias and topical ophthalmic chloramphenicol. Am J Ophthalmol, 115, 812

10.1016/S0002-9394(14)76851-5

Flach AJ, 1988, 5% in reducing postoperative inflammation after cataract extraction and intraocular lens implantation. Ophthalmology, 95, 1279

Flach AJ, 1990, A paired-comparison, placebo-controlled double-masked study. Ophthalmology, 97, 1253

Solomon KD, 2001, 5% ophthalmic solution in ocular inflammation after cataract surgery. Ophthalmology, 108, 331

Sharma A, 1997, 5% solution for the treatment of vernal keratoconjunctivitis. Indian J Ophthalmol, 45, 177

Srinivasan BD, 1989, Prog Clin Biol Res, 312, 229

10.1016/S0886-3350(00)00439-9

Solomon KD, 2004, Safety and efficacy of ketorolac tromethamine 0.4% ophthalmic solution in post-photorefractive keratectomy patients. J Cataract Refract Surg, 30, 1653

Price MO, 2004, 4% for control of pain or discomfort associated with cataract surgery. Curr Med Res Opin, 20, 2015

Jett MF, 1999, J Pharmacol Exp Ther, 288, 1288

Pallapies D, 1995, Effects of lysine clonixinate and ketorolac tromethamine on prostanoid release from various rat organs incubated ex vivo. Life Sci, 57, 83

10.1089/1080768041725380

10.1073/pnas.96.13.7563

10.1089/jop.2000.16.481

10.1111/j.1572-0241.1999.01093.x

10.1002/lt.500050607

10.1345/aph.18364

10.2165/00003088-199936060-00002